Q2 2019 Holdings
Filed 2019-08-14 | 6 holdings | $48.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $48.1M | 2,429,999 | 99.7% |
| Eyepoint Pharmaceuticals Inc | COM | 30233G100 | $68.7K | 41,909,219 | 0.1% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $43.3K | 3,342,047 | 0.1% |
| Medicinova Inc(MNOV) | COM NEW | 58468P206 | $11.3K | 1,170,370 | 0.0% |
| Endologix Inc(ELGXEUR) | COM NEW | 29266S304 | $1.4K | 125,747 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $579 | 78,622 | 0.0% |